Adam Kobayashi Selected Research

Nitric Oxide (Nitrogen Monoxide)

3/2008

Efficacy of Nitric Oxide in Stroke - a randomized trial. Characteristics of patients recruited in Poland.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam Kobayashi Research Topics

Disease

31	Stroke (Strokes) 09/2022 - 01/2003
16	Ischemic Stroke 12/2023 - 11/2006
5	Atrial Fibrillation 01/2020 - 01/2005
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 10/2018
3	Hemorrhage 01/2024 - 01/2017
3	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2022 - 10/2018
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2017 - 08/2015
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021 - 03/2009
2	Carotid Stenosis (Carotid Artery Stenosis) 03/2020 - 05/2009
2	Infections 01/2020 - 01/2020
2	COVID-19 01/2020 - 01/2020
2	Hematoma 01/2018 - 11/2006
2	Hypertension (High Blood Pressure) 10/2015 - 03/2008
1	Hemorrhagic Stroke 01/2024
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Endocarditis 01/2020
1	Cerebral Hemorrhage 01/2018
1	Venous Thromboembolism 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2015
1	Infarction (Infarctions) 08/2015
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 08/2015
1	Aneurysm (Aneurysms) 03/2009
1	Seizures (Absence Seizure) 02/2007

Drug/Important Bio-Agent (IBA)

12	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2023 - 11/2006
9	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2021 - 09/2006
6	AnticoagulantsIBA 01/2024 - 11/2013
6	Dabigatran FDA Link 01/2022 - 01/2017
5	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 11/2015
5	Antihypertensive Agents (Antihypertensives)IBA 10/2015 - 03/2008
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2015 - 11/2013
2	RivaroxabanIBA 01/2024 - 01/2017
2	apixabanIBA 01/2024 - 01/2017
2	Vitamin K FDA Link 10/2018 - 10/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2013 - 01/2005
1	PRT064445IBA 01/2024
1	AntidotesIBA 01/2024
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	TroponinIBA 01/2020
1	vinyltriethoxysilane (VTES)IBA 12/2019
1	Heparin (Liquaemin)FDA LinkGeneric 10/2018
1	edoxabanIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2013
1	2,6-dinitrotoluene (DNT)IBA 06/2012
1	Fibrinogen (Factor I)FDA Link 07/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2008
1	Nitroglycerin (Dynamite)FDA LinkGeneric 03/2008
1	NitratesIBA 03/2008
1	Blood Glucose (Blood Sugar)IBA 02/2007

Therapy/Procedure

5	Therapeutics 01/2024 - 11/2006
5	Thrombectomy 01/2021 - 09/2017
3	Drug Therapy (Chemotherapy) 01/2022 - 11/2013
3	Stents 01/2021 - 03/2009
3	Thrombolytic Therapy 03/2009 - 11/2006
2	Time-to-Treatment 12/2012 - 01/2012
1	Long-Term Care 01/2020
1	Decompression 01/2018
1	Punctures 09/2017
1	Contraindications 08/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2009
1	Embolectomy 09/2008
1	Estrogen Replacement Therapy 01/2003